Syndeio is a synapse-focused biotech pioneering a new class of therapies for neuropsychiatric and cognitive disorders, utilizing event-driven pharmacology to enhance synaptic health and restore brain function
Syndeio is a synapse-focused biotech pioneering a new class of therapies for neuropsychiatric and cognitive disorders, utilizing event-driven pharmacology to enhance synaptic health and restore brain function.